Neurology Clinical Trials Market Size, Share, Growth, and Industry Analysis, By Types (Interventional, Observational, Expanded Access, ), By Applications (Epilepsy, Parkinson's Disease (PD), Huntington's Disease, Stroke, Traumatic Brain Injury (TBI), Amyotrophic Lateral Sclerosis (ALS), Muscle regeneration, Others, ) , and Regional Insights and Forecast to 2035

Table of Content



1 Market Overview

1.1 Product Definition and Market Characteristics

1.2 Global Neurology Clinical Trials Market Size

1.3 Market Segmentation

1.4 Regulatory Environment



2 Industry Chain Analysis

2.1 Industry Chain Analysis

2.2 Neurology Clinical Trials Raw Materials Analysis

2.2.1 Key Raw Materials Introduction

2.2.2 Key Suppliers of Raw Materials

2.3 Neurology Clinical Trials Business Mode and Production Process

2.3.1 Neurology Clinical Trials Business Mode Analysis

2.3.2 Production Process Analysis

2.4 Neurology Clinical Trials Cost Structure Analysis

2.4.1 Manufacturing Cost Structure of Neurology Clinical Trials

2.4.2 Raw Material Cost of Neurology Clinical Trials

2.4.3 Labor Cost of Neurology Clinical Trials

2.5 Market Channel Analysis

2.6 Major Downstream Customers Analysis

2.7 Alternative Product Analysis



3 Market Dynamics

3.1 Market Drivers

3.2 Market Constraints and Challenges

3.3 Emerging Market Trends

3.4 PESTEL Analysis

3.5 Consumer Insights Analysis

3.6 Impact of Russia and Ukraine War



4 Market Competitive Landscape

4.1 Global Neurology Clinical Trials Revenue and Market Share by Manufacturer (2021-2026)

4.2 Global Neurology Clinical Trials Sales Volume and Market Share by Manufacturer (2021-2026)

4.3 Global Neurology Clinical Trials Price by Manufacturer (2021-2026)

4.4 Neurology Clinical Trials Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

4.5 Global Key Manufacturers of Neurology Clinical Trials, Manufacturing Base Distribution and Headquarters

4.6 Global Key Manufacturers of Neurology Clinical Trials, Product Offered and Application

4.7 Neurology Clinical Trials Market Competitive Situation and Trends

4.7.1 Neurology Clinical Trials Market Concentration Rate

4.7.2 Global Top 3 and Top 6 Neurology Clinical Trials Players Market Share by Revenue

4.8 Industry News

4.8.1 Key Product Launch News

4.8.2 Mergers & Acquisitions, Expansion Plans



5 Global Neurology Clinical Trials Market Historical Development by Geographic Region (2021-2026)

5.1 Global Neurology Clinical Trials Market Historical Sales Volume by Geographic Region (2021-2026)

5.2 Global Neurology Clinical Trials Market Historical Revenue by Geographic Region (2021-2026)

5.3 North America Neurology Clinical Trials Market Status by Country (2021-2026)

5.3.1 North America Neurology Clinical Trials Sales Volume by Country (2021-2026)

5.3.2 North America Neurology Clinical Trials Revenue by Country (2021-2026)

5.3.3 United States Neurology Clinical Trials Sales Volume, Revenue and Growth (2021-2026)

5.3.4 Canada Neurology Clinical Trials Sales Volume, Revenue and Growth (2021-2026)

5.4 Europe Neurology Clinical Trials Market Status by Country (2021-2026)

5.4.1 Europe Neurology Clinical Trials Sales Volume by Country (2021-2026)

5.4.2 Europe Neurology Clinical Trials Revenue by Country (2021-2026)

5.4.3 Germany Neurology Clinical Trials Sales Volume, Revenue and Growth (2021-2026)

5.4.4 France Neurology Clinical Trials Sales Volume, Revenue and Growth (2021-2026)

5.4.5 United Kingdom Neurology Clinical Trials Sales Volume, Revenue and Growth (2021-2026)

5.4.6 Spain Neurology Clinical Trials Sales Volume, Revenue and Growth (2021-2026)

5.4.7 Russia Neurology Clinical Trials Sales Volume, Revenue and Growth (2021-2026)

5.4.8 Poland Neurology Clinical Trials Sales Volume, Revenue and Growth (2021-2026)

5.5 Asia Pacific Neurology Clinical Trials Market Status by Country (2021-2026)

5.5.1 Asia Pacific Neurology Clinical Trials Sales Volume by Country (2021-2026)

5.5.2 Asia Pacific Neurology Clinical Trials Revenue by Country (2021-2026)

5.5.3 China Neurology Clinical Trials Sales Volume, Revenue and Growth (2021-2026)

5.5.4 Japan Neurology Clinical Trials Sales Volume, Revenue and Growth (2021-2026)

5.5.5 South Korea Neurology Clinical Trials Sales Volume, Revenue and Growth (2021-2026)

5.5.6 Southeast Asia Neurology Clinical Trials Sales Volume, Revenue and Growth (2021-2026)

5.5.7 India Neurology Clinical Trials Sales Volume, Revenue and Growth (2021-2026)

5.5.8 Australia Neurology Clinical Trials Sales Volume, Revenue and Growth (2021-2026)

5.6 Latin America Neurology Clinical Trials Market Status by Country (2021-2026)

5.6.1 Latin America Neurology Clinical Trials Sales Volume by Country (2021-2026)

5.6.2 Latin America Neurology Clinical Trials Revenue by Country (2021-2026)

5.6.3 Mexico Neurology Clinical Trials Sales Volume, Revenue and Growth (2021-2026)

5.6.4 Brazil Neurology Clinical Trials Sales Volume, Revenue and Growth (2021-2026)

5.7 Middle East and Africa Neurology Clinical Trials Market Status by Country (2021-2026)

5.7.1 Middle East and Africa Neurology Clinical Trials Sales Volume by Country (2021-2026)

5.7.2 Middle East and Africa Neurology Clinical Trials Revenue by Country (2021-2026)

5.7.3 GCC Neurology Clinical Trials Sales Volume, Revenue and Growth (2021-2026)

5.7.4 South Africa Neurology Clinical Trials Sales Volume, Revenue and Growth (2021-2026)



6 Global Neurology Clinical Trials Market Historical Development by Product Type (2021-2026)

6.1 Neurology Clinical Trials Definition by Type

6.2 Global Neurology Clinical Trials Historical Sales Volume by Product Type (2021-2026)

6.3 Global Neurology Clinical Trials Historical Revenue by Product Type (2021-2026)

6.4 Global Neurology Clinical Trials Historical Price by Product Type (2021-2026)

6.5 Global Historical Sales Volume, Revenue and Growth Rate by Product Type (2021-2026)

6.5.1 Global Neurology Clinical Trials Historical Sales Volume, Revenue and Growth Rate of Interventional (2021-2026)
6.5.2 Global Neurology Clinical Trials Historical Sales Volume, Revenue and Growth Rate of Observational (2021-2026)
6.5.3 Global Neurology Clinical Trials Historical Sales Volume, Revenue and Growth Rate of Expanded Access (2021-2026)


7 Global Neurology Clinical Trials Market Historical Development by End User (2021-2026)

7.1 Downstream Market Overview

7.2 Global Neurology Clinical Trials Historical Sales Volume by End User (2021-2026)

7.3 Global Neurology Clinical Trials Historical Revenue by End User (2021-2026)

7.4 Global Neurology Clinical Trials Historical Price by End User (2021-2026)

7.5 Global Historical Sales Volume, Revenue and Growth Rate by End User (2021-2026)

7.5.1 Global Neurology Clinical Trials Historical Sales Volume, Revenue and Growth Rate of Epilepsy (2021-2026)
7.5.2 Global Neurology Clinical Trials Historical Sales Volume, Revenue and Growth Rate of Parkinson's Disease (PD) (2021-2026)
7.5.3 Global Neurology Clinical Trials Historical Sales Volume, Revenue and Growth Rate of Huntington's Disease (2021-2026)
7.5.4 Global Neurology Clinical Trials Historical Sales Volume, Revenue and Growth Rate of Stroke (2021-2026)
7.5.5 Global Neurology Clinical Trials Historical Sales Volume, Revenue and Growth Rate of Traumatic Brain Injury (TBI) (2021-2026)
7.5.6 Global Neurology Clinical Trials Historical Sales Volume, Revenue and Growth Rate of Amyotrophic Lateral Sclerosis (ALS) (2021-2026)
7.5.7 Global Neurology Clinical Trials Historical Sales Volume, Revenue and Growth Rate of Muscle regeneration (2021-2026)
7.5.8 Global Neurology Clinical Trials Historical Sales Volume, Revenue and Growth Rate of Others (2021-2026)


8 Leading Companies Profiles

8.1 Med pace
8.1.1 Med pace Corporation Information
8.1.2 Med pace - Neurology Clinical Trials Product Portfolio and Specification
8.1.3 Med pace Performance Analysis (2021-2026)
8.1.4 Med pace Business and Markets Served
8.1.5 Med pace Recent Developments
8.2 Charles River Laboratories
8.2.1 Charles River Laboratories Corporation Information
8.2.2 Charles River Laboratories - Neurology Clinical Trials Product Portfolio and Specification
8.2.3 Charles River Laboratories Performance Analysis (2021-2026)
8.2.4 Charles River Laboratories Business and Markets Served
8.2.5 Charles River Laboratories Recent Developments
8.3 Aurora healthcare
8.3.1 Aurora healthcare Corporation Information
8.3.2 Aurora healthcare - Neurology Clinical Trials Product Portfolio and Specification
8.3.3 Aurora healthcare Performance Analysis (2021-2026)
8.3.4 Aurora healthcare Business and Markets Served
8.3.5 Aurora healthcare Recent Developments
8.4 Covance
8.4.1 Covance Corporation Information
8.4.2 Covance - Neurology Clinical Trials Product Portfolio and Specification
8.4.3 Covance Performance Analysis (2021-2026)
8.4.4 Covance Business and Markets Served
8.4.5 Covance Recent Developments
8.5 IQVIA
8.5.1 IQVIA Corporation Information
8.5.2 IQVIA - Neurology Clinical Trials Product Portfolio and Specification
8.5.3 IQVIA Performance Analysis (2021-2026)
8.5.4 IQVIA Business and Markets Served
8.5.5 IQVIA Recent Developments
8.6 Novartis
8.6.1 Novartis Corporation Information
8.6.2 Novartis - Neurology Clinical Trials Product Portfolio and Specification
8.6.3 Novartis Performance Analysis (2021-2026)
8.6.4 Novartis Business and Markets Served
8.6.5 Novartis Recent Developments
8.7 Syneous Health
8.7.1 Syneous Health Corporation Information
8.7.2 Syneous Health - Neurology Clinical Trials Product Portfolio and Specification
8.7.3 Syneous Health Performance Analysis (2021-2026)
8.7.4 Syneous Health Business and Markets Served
8.7.5 Syneous Health Recent Developments
8.8 Icon Plc.
8.8.1 Icon Plc. Corporation Information
8.8.2 Icon Plc. - Neurology Clinical Trials Product Portfolio and Specification
8.8.3 Icon Plc. Performance Analysis (2021-2026)
8.8.4 Icon Plc. Business and Markets Served
8.8.5 Icon Plc. Recent Developments
8.9 GlaxoSmithKline
8.9.1 GlaxoSmithKline Corporation Information
8.9.2 GlaxoSmithKline - Neurology Clinical Trials Product Portfolio and Specification
8.9.3 GlaxoSmithKline Performance Analysis (2021-2026)
8.9.4 GlaxoSmithKline Business and Markets Served
8.9.5 GlaxoSmithKline Recent Developments
8.10 Biogen
8.10.1 Biogen Corporation Information
8.10.2 Biogen - Neurology Clinical Trials Product Portfolio and Specification
8.10.3 Biogen Performance Analysis (2021-2026)
8.10.4 Biogen Business and Markets Served
8.10.5 Biogen Recent Developments


9 Global Neurology Clinical Trials Market Forecast by Product Type and End User (2026-2034)

9.1 Global Neurology Clinical Trials Market Forecast by Product Type (2026-2034)

9.1.1 Global Neurology Clinical Trials Sales Volume, Revenue Forecast and Growth Rate of Interventional (2026-2034)
9.1.2 Global Neurology Clinical Trials Sales Volume, Revenue Forecast and Growth Rate of Observational (2026-2034)
9.1.3 Global Neurology Clinical Trials Sales Volume, Revenue Forecast and Growth Rate of Expanded Access (2026-2034)
9.2 Global Neurology Clinical Trials Market Forecast by End User (2026-2034)

9.2.1 Global Neurology Clinical Trials Sales Volume, Revenue Forecast and Growth Rate of Epilepsy (2026-2034)
9.2.2 Global Neurology Clinical Trials Sales Volume, Revenue Forecast and Growth Rate of Parkinson's Disease (PD) (2026-2034)
9.2.3 Global Neurology Clinical Trials Sales Volume, Revenue Forecast and Growth Rate of Huntington's Disease (2026-2034)
9.2.4 Global Neurology Clinical Trials Sales Volume, Revenue Forecast and Growth Rate of Stroke (2026-2034)
9.2.5 Global Neurology Clinical Trials Sales Volume, Revenue Forecast and Growth Rate of Traumatic Brain Injury (TBI) (2026-2034)
9.2.6 Global Neurology Clinical Trials Sales Volume, Revenue Forecast and Growth Rate of Amyotrophic Lateral Sclerosis (ALS) (2026-2034)
9.2.7 Global Neurology Clinical Trials Sales Volume, Revenue Forecast and Growth Rate of Muscle regeneration (2026-2034)
9.2.8 Global Neurology Clinical Trials Sales Volume, Revenue Forecast and Growth Rate of Others (2026-2034)


10 Global Neurology Clinical Trials Market Forecast by Geographic Region (2026-2034)

10.1 Global Neurology Clinical Trials Sales Volume and Revenue Forecast by Geographic Region (2026-2034)

10.2 North America Neurology Clinical Trials Sales Volume, Revenue Forecast and Growth (2026-2034)

10.2.1 United States Neurology Clinical Trials Sales Volume, Revenue Forecast and Growth (2026-2034)

10.2.2 Canada Neurology Clinical Trials Sales Volume, Revenue Forecast and Growth (2026-2034)

10.3 Europe Neurology Clinical Trials Sales Volume, Revenue Forecast and Growth (2026-2034)

10.3.1 Germany Neurology Clinical Trials Sales Volume, Revenue Forecast and Growth (2026-2034)

10.3.2 France Neurology Clinical Trials Sales Volume, Revenue Forecast and Growth (2026-2034)

10.3.3 United Kingdom Neurology Clinical Trials Sales Volume, Revenue Forecast and Growth (2026-2034)

10.3.4 Spain Neurology Clinical Trials Sales Volume, Revenue Forecast and Growth (2026-2034)

10.3.5 Russia Neurology Clinical Trials Sales Volume, Revenue Forecast and Growth (2026-2034)

10.3.6 Poland Neurology Clinical Trials Sales Volume, Revenue Forecast and Growth (2026-2034)

10.4 Asia Pacific Neurology Clinical Trials Sales Volume, Revenue Forecast and Growth (2026-2034)

10.4.1 China Neurology Clinical Trials Sales Volume, Revenue Forecast and Growth (2026-2034)

10.4.2 Japan Neurology Clinical Trials Sales Volume, Revenue Forecast and Growth (2026-2034)

10.4.3 South Korea Neurology Clinical Trials Sales Volume, Revenue Forecast and Growth (2026-2034)

10.4.4 Southeast Asia Neurology Clinical Trials Sales Volume, Revenue Forecast and Growth (2026-2034)

10.4.5 India Neurology Clinical Trials Sales Volume, Revenue Forecast and Growth (2026-2034)

10.4.6 Australia Neurology Clinical Trials Sales Volume, Revenue Forecast and Growth (2026-2034)

10.5 Latin America Neurology Clinical Trials Sales Volume, Revenue Forecast and Growth (2026-2034)

10.5.1 Mexico Neurology Clinical Trials Sales Volume, Revenue Forecast and Growth (2026-2034)

10.5.2 Brazil Neurology Clinical Trials Sales Volume, Revenue Forecast and Growth (2026-2034)

10.6 Middle East and Africa Neurology Clinical Trials Sales Volume, Revenue Forecast and Growth (2026-2034)

10.6.1 GCC Neurology Clinical Trials Sales Volume, Revenue Forecast and Growth (2026-2034)

10.6.2 South Africa Neurology Clinical Trials Sales Volume, Revenue Forecast and Growth (2026-2034)



11 Appendix

11.1 Methodology

11.2 Research Data Source

11.2.1 Secondary Data

11.2.2 Primary Data

11.2.3 Market Size Estimation

11.2.4 Legal Disclaimer